MINNEAPOLIS, Oct. 17, 2016 /PRNewswire/ -- Nonin Medical, Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, today announced it has launched the next generation of end-tidal CO2 monitors in the LifeSense® II capnograph/pulse oximeter and RespSense® II capnograph.
The Nonin LifeSense II and RespSense II are value-priced monitors that are ideal for a wide range of medical monitoring applications where a stand-alone capnograph is desirable, including resuscitation, procedural sedation, pain management, post-anesthesia monitoring and sleep testing.
"The LifeSense II and RespSense II, with their accuracy, ease of use, cost effectiveness and leading warranty, provide tremendous value for a variety of applications and markets; including hospital, homecare, sleep labs and EMS," said Jill Wroblewski, senior director of marketing at Nonin Medical.
With both devices, clinicians have first-breath detection of respiratory rate and end-tidal CO2 (EtCO2). In addition, the LifeSense II adds Nonin's proven PureSAT® SpO2 technology which utilizes intelligent pulse-by-pulse filtering to provide precise oximetry measurements. They offer key benefits over first-generation LifeSense and RespSense products with a larger display, internal memory with USB and multiple settings options, among many others.
"We chose Nonin capnography products because they best met our criteria for construction, graphics and portability, warranty policies and consumables pricing," said Pamela S. Lindemann, MA RRT RCP, head of the respiratory therapy department at Riverside Medical Center in Kankakee, Ill.
Nonin LifeSense II and RespSense II product highlights include:
- Fast and accurate first-breath technology
- Meets rigorous ISO requirements for EMS transport
- Trending of measured parameters
- Easy-to-use, large 7 in (17 cm), color touchscreen display
- 36-hour internal memory with USB port
- Configurable selections for language, units of measurement and alarms
- Industry leading 3-year warranty
The Nonin LifeSense II and RespSense II will launch in the U.S. and be on display at the American Association for Respiratory Care (AARC) Congress, through October 18, 2016 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
The monitors will be available through select Nonin distributors. To locate a distributor or learn more, visit nonin.com/capnographs.
About Nonin Medical, Inc.
Nonin Medical, Inc. invented the finger pulse oximeter (the original Onyx® brand) and is known for Making Noninvasive Measurements Simple™. The company designs and manufactures noninvasive medical monitoring solutions that meet customers' technology needs today and tomorrow.
Headquartered in Plymouth, Minn., USA, with an additional customer service center in Amsterdam, the Netherlands, Nonin Medical sells its pulse and regional oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries. The company has more than 300 OEM partners worldwide. For more information, visit nonin.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nonin-medical-launches-next-generation-lifesense-ii-and-respsense-ii-capnographs-300345868.html
SOURCE Nonin Medical, Inc.